• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    AbbVie To Rally Over 22%? Here Are 10 Top Analyst Forecasts For Monday

    10/30/23 7:49:37 AM ET
    $ABBV
    $AX
    $BCPC
    $CUBE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Savings Institutions
    Finance
    Get the next $ABBV alert in real time by email

    Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

    • Barclays increased AbbVie Inc. (NYSE:ABBV) price target from $160 to $170. Barclays analyst Carter Gould upgraded the stock from Equal-Weight to Overweight. AbbVie shares fell 4.3% to close at $138.93 on Friday. See how other analysts view this stock.
    • JP Morgan cut the price target for Olin Corporation (NYSE:OLN) from $75 to $48. JP Morgan analyst Jeffrey Zekauskas downgraded the stock from Overweight to Neutral. Olin shares fell 9% to close at $42.12 on Friday. See how other analysts view this stock.
    • UBS increased East West Bancorp, Inc. (NASDAQ:EWBC) price target from $57 to $61. UBS analyst Brody Preston upgraded the stock from Neutral to Buy. East West Bancorp shares gained 1.6% to $53.50 in pre-market trading. See how other analysts view this stock.
    • Raymond James slashed the price target for Chevron Corporation (NYSE:CVX) from $200 to $175. Raymond James analyst Justin Jenkins maintained an Outperform rating. Chevron shares gained 1.8% to $146.87 in pre-market trading. See how other analysts view this stock.
    • Keybanc cut the price target for Eastman Chemical Company (NYSE:EMN) from $98 to $95. Keybanc analyst Aleksey Yefremov maintained an Overweight rating. Eastman Chemical shares rose 3.5% to close at $72.58 on Friday. See how other analysts view this stock.
    • Wells Fargo cut NorthWestern Energy Group, Inc. (NYSE:NWE) price target from $59 to $51. Wells Fargo analyst Jonathan Reeder upgraded the stock from Equal-Weight to Overweight. NorthWestern Energy shares fell 2.3% to close at $46.55 on Friday. See how other analysts view this stock.
    • Baird slashed Datadog, Inc. (NASDAQ:DDOG) price target from $100 to $84. Baird analyst William Power downgraded the stock from Outperform to Neutral. Datadog shares fell 0.7% to $81.13 in pre-market trading. See how other analysts view this stock.
    • HC Wainwright & Co. cut the price target for Balchem Corporation (NASDAQ:BCPC) from $165 to $135. HC Wainwright & Co. analyst Raghuram Selvaraju maintained a Buy rating. Balchem shares fell 5.4% to close at $115.08 on Friday. See how other analysts view this stock.
    • B of A Securities cut CubeSmart (NYSE:CUBE) price target from $51 to $38. B of A Securities analyst Jeffrey Spector downgraded the stock from Buy to Neutral. CubeSmart shares fell 0.7% to close at $33.98 on Friday. See how other analysts view this stock.
    • Raymond James cut Axos Financial, Inc. (NYSE:AX) price target from $55 to $45. Raymond James analyst David Feaster maintained an Outperform rating. Axos Financial shares fell 7.8% to close at $34.85 on Friday. See how other analysts view this stock.

     

    Check This Out: Fear Among US Investors Is Growing; Fear & Greed Index Moves To 'Extreme Fear' Zone

    Get the next $ABBV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ABBV
    $AX
    $BCPC
    $CUBE

    CompanyDatePrice TargetRatingAnalyst
    Chevron Corporation
    $CVX
    2/17/2026$205.00Hold → Buy
    Melius
    Chevron Corporation
    $CVX
    2/2/2026$160.00 → $168.00Hold
    TD Cowen
    Chevron Corporation
    $CVX
    2/2/2026$180.00Buy → Hold
    HSBC Securities
    Datadog Inc.
    $DDOG
    1/29/2026$215.00 → $170.00Outperform
    BMO Capital Markets
    Datadog Inc.
    $DDOG
    1/27/2026$190.00Buy
    Daiwa Securities
    CubeSmart
    $CUBE
    1/26/2026Outperform → Peer Perform
    Wolfe Research
    Datadog Inc.
    $DDOG
    1/22/2026$160.00Hold → Buy
    Stifel
    NorthWestern Energy Group Inc.
    $NWE
    1/20/2026$53.00Equal Weight → Underweight
    Wells Fargo
    More analyst ratings

    $ABBV
    $AX
    $BCPC
    $CUBE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, AFP, Mfg., WWEC & HSE Smith Brian Travis bought $119,595 worth of shares (1,750 units at $68.34), increasing direct ownership by 12% to 16,732 units (SEC Form 4)

    4 - EASTMAN CHEMICAL CO (0000915389) (Issuer)

    8/29/25 4:01:38 PM ET
    $EMN
    Major Chemicals
    Industrials

    Director Obrien James J /Ky bought $99,776 worth of shares (1,450 units at $68.81), increasing direct ownership by 27% to 6,828 units (SEC Form 4)

    4 - EASTMAN CHEMICAL CO (0000915389) (Issuer)

    8/28/25 4:14:09 PM ET
    $EMN
    Major Chemicals
    Industrials

    Director Mink Kim Ann bought $100,601 worth of shares (1,450 units at $69.38), increasing direct ownership by 104% to 2,840 units (SEC Form 4)

    4 - EASTMAN CHEMICAL CO (0000915389) (Issuer)

    8/28/25 4:13:44 PM ET
    $EMN
    Major Chemicals
    Industrials

    $ABBV
    $AX
    $BCPC
    $CUBE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Juvenile Idiopathic Arthritis Market is Expected to Expand at a Healthy Growth Rate of 5.6% During the Forecast Period (2026-2036) | DelveInsight

    The juvenile idiopathic arthritis market is experiencing steady growth driven by rising disease awareness, improved diagnostic capabilities, and expanding access to advanced biologic therapies. Additionally, the launch of emerging therapies such as SOTYKTU (Bristol-Myers Squibb), BIMZELX (UCB Biopharma), MAS825 (Novartis), and others will further propel the market forward.LAS VEGAS, Feb. 17, 2026 /PRNewswire/ -- Recently published Juvenile Idiopathic Arthritis Market Insights report includes a comprehensive understanding of current treatment practices, juvenile idiopathic arthritis emerging drugs, market share of individual therapies, and current and forecasted market size from 2022 to 2036,

    2/17/26 5:31:00 PM ET
    $ABBV
    $BMY
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Atopic Dermatitis Market to Accelerate at a Rapid Pace by 2034 with Advancements in Biologics and JAK Inhibitors | DelveInsight

    The atopic dermatitis market is expected to grow, driven by the extensive market penetration of approved therapies for moderate-to-severe atopic dermatitis and the entry of new therapies such as OX40 inhibitor (Rocatinlimab [KHK4083/AMG451]), OX40L inhibitor (Amlitelimab [KY1005]), PDE4 inhibitor (Orismilast), TSLP inhibitor (Bosakitug [BSI-045B]), IL-22RA1 blocker (Temtokibart [LP0145; LEO 138559]), IL-4Rα blocker (Rademikibart [CBP-201]), and others.LAS VEGAS, Feb. 16, 2026 /PRNewswire/ -- Recently published Atopic Dermatitis Market Insights report includes a comprehensive understanding of current treatment practices, atopic dermatitis emerging drugs, market share of individual therapies,

    2/16/26 5:31:00 PM ET
    $ABBV
    $AMGN
    $APGE
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)
    Biotechnology: Commercial Physical & Biological Resarch

    Chevron Awarded Four Offshore Leases for Greece Exploration Blocks

    Supports strategy to enhance exploration portfolio and efforts in Mediterranean region Chevron Corporation (NYSE:CVX), via its four Dutch subsidiaries, together with HELLENiQ ENERGY has today signed Lease Agreements with the Hellenic Republic which will enable exploration of four blocks offshore Greece. The blocks are located south of Crete (South Crete 1, South Crete 2) and within the Peloponnese (South of Peloponnese, and Block A2). The awarded consortium, in which Chevron holds a 70% operating interest and HELLENiQ ENERGY a 30% interest, was selected following an international call for tender launched by the Greek government in 2025. "This is another important milestone for Chevron

    2/16/26 7:05:00 AM ET
    $CVX
    Integrated oil Companies
    Energy

    $ABBV
    $AX
    $BCPC
    $CUBE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Chevron upgraded by Melius with a new price target

    Melius upgraded Chevron from Hold to Buy and set a new price target of $205.00

    2/17/26 7:31:07 AM ET
    $CVX
    Integrated oil Companies
    Energy

    TD Cowen reiterated coverage on Chevron with a new price target

    TD Cowen reiterated coverage of Chevron with a rating of Hold and set a new price target of $168.00 from $160.00 previously

    2/2/26 7:18:00 AM ET
    $CVX
    Integrated oil Companies
    Energy

    Chevron downgraded by HSBC Securities with a new price target

    HSBC Securities downgraded Chevron from Buy to Hold and set a new price target of $180.00

    2/2/26 6:48:45 AM ET
    $CVX
    Integrated oil Companies
    Energy

    $ABBV
    $AX
    $BCPC
    $CUBE
    SEC Filings

    View All

    NorthWestern Energy Group Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - NorthWestern Energy Group, Inc. (0001993004) (Filer)

    2/17/26 4:32:54 PM ET
    $NWE
    Power Generation
    Utilities

    SEC Form FWP filed by Eastman Chemical Company

    FWP - EASTMAN CHEMICAL CO (0000915389) (Subject)

    2/17/26 4:10:01 PM ET
    $EMN
    Major Chemicals
    Industrials

    SEC Form 424B5 filed by Eastman Chemical Company

    424B5 - EASTMAN CHEMICAL CO (0000915389) (Filer)

    2/17/26 8:55:37 AM ET
    $EMN
    Major Chemicals
    Industrials

    $ABBV
    $AX
    $BCPC
    $CUBE
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for VYALEV issued to ABBVIE INC

    Submission status for ABBVIE INC's drug VYALEV (ORIG-1) with active ingredient FOSCARBIDOPA AND FOSLEVODOPA has changed to 'Approval' on 10/16/2024. Application Category: NDA, Application Number: 216962, Application Classification: Type 3 - New Dosage Form and Type 4 - New Combination

    10/18/24 4:38:13 AM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for VYALEV issued to ABBVIE INC

    Submission status for ABBVIE INC's drug VYALEV (ORIG-1) with active ingredient FOSCARBIDOPA AND FOSLEVODOPA has changed to 'Approval' on 10/16/2024. Application Category: NDA, Application Number: 216962, Application Classification: Type 3 - New Dosage Form

    10/17/24 1:29:31 PM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SKYRIZI issued to ABBVIE INC

    Submission status for ABBVIE INC's drug SKYRIZI (SUPPL-7) with active ingredient RISANKIZUMAB-RZAA has changed to 'Approval' on 06/18/2024. Application Category: BLA, Application Number: 761262, Application Classification:

    6/21/24 4:38:17 AM ET
    $ABBV
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ABBV
    $AX
    $BCPC
    $CUBE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SVP and GM, Specialty Products Van Gunsteren Job Leonard was granted 1,775 shares and covered exercise/tax liability with 814 shares, increasing direct ownership by 10% to 10,149 units (SEC Form 4)

    4 - BALCHEM CORP (0000009326) (Issuer)

    2/13/26 7:11:01 PM ET
    $BCPC
    Major Chemicals
    Industrials

    SVP Chief Supply Chain Officer Reid Martin Luther was granted 3,299 shares and covered exercise/tax liability with 1,201 shares, increasing direct ownership by 30% to 9,073 units (SEC Form 4)

    4 - BALCHEM CORP (0000009326) (Issuer)

    2/13/26 7:05:59 PM ET
    $BCPC
    Major Chemicals
    Industrials

    Chairman, President & CEO Harris Theodore L was granted 25,641 shares and covered exercise/tax liability with 10,202 shares, increasing direct ownership by 20% to 91,373 units (SEC Form 4)

    4 - BALCHEM CORP (0000009326) (Issuer)

    2/13/26 6:51:17 PM ET
    $BCPC
    Major Chemicals
    Industrials

    $ABBV
    $AX
    $BCPC
    $CUBE
    Leadership Updates

    Live Leadership Updates

    View All

    UPDATE ICIC Announces Board Chair Transition:

    Boston, MA, Jan. 13, 2026 (GLOBE NEWSWIRE) -- The Initiative for a Competitive Inner City (ICIC) today announced a leadership transition within its Board of Directors. Ronald A. Homer, who has served as Chair of ICIC's Board of Directors for the past five years, stepped down from the Chair role at the end of 2025 and continues his service as a member of the Board. Jair K. Lynch, President and CEO of Jair Lynch Real Estate Partners, has been unanimously elected to succeed Ronald Homer as Chair of the Board. Board Leadership Transition at ICIC This transition marks a new chapter in ICIC's more than 30-year history, following two prior Board Chairs: Michael E. Porter, ICIC's founder, and

    1/13/26 2:29:21 PM ET
    $CUBE
    Real Estate Investment Trusts
    Real Estate

    ICIC Announces Board Chair Transition:

    Boston, MA, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The Initiative for a Competitive Inner City (ICIC) today announced a leadership transition within its Board of Directors. Ronald A. Homer, who has served as Chair of ICIC's Board of Directors for the past five years, will step down from the Chair role at the end of 2025 and continue his service as a member of the Board. Jair K. Lynch, President and CEO of Jair Lynch Real Estate Partners, has been unanimously elected to succeed Ronald Homer as Chair of the Board. Board Leadership Transition at ICIC This transition marks a new chapter in ICIC's more than 30-year history, following two prior Board Chairs: Michael E. Porter, ICIC's founder, and

    1/12/26 2:40:01 PM ET
    $CUBE
    Real Estate Investment Trusts
    Real Estate

    Eastman Schedules Fourth-Quarter and Full-Year 2025 Financial Results News Release and SEC Form 8-K Filing, Teleconference and Webcast, and Release of Additional Information

    Eastman Chemical Company (NYSE:EMN): Financial Results Release: Thursday, Jan. 29, 2026 Approximately 4:15 p.m. Eastern Time Via wire distribution and www.eastman.com, News Center and SEC Form 8-K filing.   Advance Slides, Webcast and Teleconference: Friday, Jan. 30, 2026 8:00 a.m. Eastern Time Via listen-only live webcast and teleconference. Advance slides and prepared remarks: posted Thursday, Jan. 29, evening at investors.eastman.com Webcast: Eastman Q4 and FY 2025 Webcast to join live webcast Teleconference: Toll-Free dial-in number +1 (833) 470-1428 Passcode: 251637   Teleconference Pre-Registration:   To spe

    1/12/26 10:00:00 AM ET
    $EMN
    Major Chemicals
    Industrials

    $ABBV
    $AX
    $BCPC
    $CUBE
    Financials

    Live finance-specific insights

    View All

    Eastman Board Declares Dividend

    The Board of Directors of Eastman Chemical Company (NYSE:EMN) has declared a quarterly cash dividend of $0.84 per share on the company's common stock. The dividend is payable April 8, 2026, to stockholders of record as of March 13, 2026. Founded in 1920, Eastman is a global specialty materials company that produces a broad range of products found in items people use every day. With the purpose of enhancing the quality of life in a material way, Eastman works with customers to deliver innovative products and solutions while maintaining a commitment to safety and sustainability. The company's innovation-driven growth model takes advantage of world-class technology platforms, deep customer

    2/12/26 4:15:00 PM ET
    $EMN
    Major Chemicals
    Industrials

    Olin to Take a Fourth Quarter 2025 Charge Following Verdict in Shintech v. Olin Litigation

    CLAYTON, Mo., Feb. 12, 2026 /PRNewswire/ -- Olin Corporation (NYSE:OLN), a leading global manufacturer and distributor of chemical products, today issued an update following a recent verdict in a litigation matter filed by Shintech Incorporated ("Shintech") against Olin Corporation and its wholly owned subsidiary, Blue Cube Operations LLC (collectively, "Olin"). In April 2023, Shintech filed a lawsuit seeking damages against Olin. The litigation involved a pricing dispute between Shintech and Olin, a 2023 maintenance turnaround of a vinyl chloride monomer (VCM) plant and a dis

    2/12/26 4:05:00 PM ET
    $OLN
    Major Chemicals
    Industrials

    Datadog Announces Fourth Quarter and Fiscal Year 2025 Financial Results

    Fourth quarter revenue grew 29% year-over-year to $953 million Strong growth of larger customers, with 603 $1 million+ ARR customers, up from 462 a year ago Launched Bits AI SRE Agent, Storage Management, Feature Flags, and Data Observability for general availability NEW YORK, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Datadog, Inc. (NASDAQ:DDOG), the AI-powered observability and security platform for cloud applications, today announced financial results for its fourth quarter and fiscal year ended December 31, 2025. "We are pleased with our strong execution in fiscal year 2025, with 28% year-over-year revenue growth, $1,050 million in operating cash flow, and $915 milli

    2/10/26 7:00:00 AM ET
    $DDOG
    Computer Software: Prepackaged Software
    Technology

    $ABBV
    $AX
    $BCPC
    $CUBE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Olin Corporation

    SC 13G/A - OLIN Corp (0000074303) (Subject)

    11/14/24 4:01:37 PM ET
    $OLN
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Balchem Corporation

    SC 13G/A - BALCHEM CORP (0000009326) (Subject)

    11/13/24 6:56:07 PM ET
    $BCPC
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by East West Bancorp Inc.

    SC 13G/A - EAST WEST BANCORP INC (0001069157) (Subject)

    11/13/24 10:22:19 AM ET
    $EWBC
    Major Banks
    Finance